Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis : A Multicenter Matched Cohort Study
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America..
BACKGROUND: Although Streptococcus anginosus group (SAG) endocarditis is considered a severe disease associated with abscess formation and embolic events, there is limited evidence to support this assumption.
METHODS: We performed a retrospective analysis of prospectively collected data from consecutive patients with definite SAG endocarditis in 28 centers in Spain and Italy. A comparison between cases due to SAG endocarditis and viridans group streptococci (VGS) or Streptococcus gallolyticus group (SGG) was performed in a 1:2 matched analysis.
RESULTS: Of 5336 consecutive cases of definite endocarditis, 72 (1.4%) were due to SAG and matched with 144 cases due to VGS/SGG. SAG endocarditis was community acquired in 64 (88.9%) cases and affected aortic native valve in 29 (40.3%). When comparing SAG and VGS/SGG endocarditis, no significant differences were found in septic shock (8.3% vs 3.5%, P = .116); valve disorder, including perforation (22.2% vs 18.1%, P = .584), pseudoaneurysm (16.7% vs 8.3%, P = .108), or prosthesis dehiscence (1.4% vs 6.3%, P = .170); paravalvular complications, including abscess (25% vs 18.8%, P = .264) and intracardiac fistula (5.6% vs 3.5%, P = .485); heart failure (34.7% vs 38.9%, P = .655); or embolic events (41.7% vs 32.6%, P = .248). Indications for surgery (70.8% vs 70.8%; P = 1) and mortality (13.9% vs 16.7%; P = .741) were similar between groups.
CONCLUSIONS: SAG endocarditis is an infrequent but serious condition that presents a prognosis similar to that of VGS/SGG.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Open forum infectious diseases - 8(2021), 6 vom: 18. Juni, Seite ofab163 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Infective endocarditis |
|---|
| Anmerkungen: |
Date Revised 24.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/ofid/ofab163 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327360534 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327360534 | ||
| 003 | DE-627 | ||
| 005 | 20231225200620.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ofid/ofab163 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1091.xml |
| 035 | |a (DE-627)NLM327360534 | ||
| 035 | |a (NLM)34189163 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Escrihuela-Vidal, Francesc |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis |b A Multicenter Matched Cohort Study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.04.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. | ||
| 520 | |a BACKGROUND: Although Streptococcus anginosus group (SAG) endocarditis is considered a severe disease associated with abscess formation and embolic events, there is limited evidence to support this assumption | ||
| 520 | |a METHODS: We performed a retrospective analysis of prospectively collected data from consecutive patients with definite SAG endocarditis in 28 centers in Spain and Italy. A comparison between cases due to SAG endocarditis and viridans group streptococci (VGS) or Streptococcus gallolyticus group (SGG) was performed in a 1:2 matched analysis | ||
| 520 | |a RESULTS: Of 5336 consecutive cases of definite endocarditis, 72 (1.4%) were due to SAG and matched with 144 cases due to VGS/SGG. SAG endocarditis was community acquired in 64 (88.9%) cases and affected aortic native valve in 29 (40.3%). When comparing SAG and VGS/SGG endocarditis, no significant differences were found in septic shock (8.3% vs 3.5%, P = .116); valve disorder, including perforation (22.2% vs 18.1%, P = .584), pseudoaneurysm (16.7% vs 8.3%, P = .108), or prosthesis dehiscence (1.4% vs 6.3%, P = .170); paravalvular complications, including abscess (25% vs 18.8%, P = .264) and intracardiac fistula (5.6% vs 3.5%, P = .485); heart failure (34.7% vs 38.9%, P = .655); or embolic events (41.7% vs 32.6%, P = .248). Indications for surgery (70.8% vs 70.8%; P = 1) and mortality (13.9% vs 16.7%; P = .741) were similar between groups | ||
| 520 | |a CONCLUSIONS: SAG endocarditis is an infrequent but serious condition that presents a prognosis similar to that of VGS/SGG | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Streptococcus anginosus | |
| 650 | 4 | |a Streptococcus gallolyticus | |
| 650 | 4 | |a infective endocarditis | |
| 650 | 4 | |a viridans group streptococci | |
| 700 | 1 | |a López-Cortés, Luis Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Escolà-Vergé, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a De Alarcón González, Arístides |e verfasserin |4 aut | |
| 700 | 1 | |a Cuervo, Guillermo |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez-Porto, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-Hidalgo, Nuria |e verfasserin |4 aut | |
| 700 | 1 | |a Luque, Rafael |e verfasserin |4 aut | |
| 700 | 1 | |a Montejo, Miguel |e verfasserin |4 aut | |
| 700 | 1 | |a Miró, José M |e verfasserin |4 aut | |
| 700 | 1 | |a Goenaga, Miguel Ángel |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a Valerio, Maricela |e verfasserin |4 aut | |
| 700 | 1 | |a Ripa, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Sousa-Regueiro, Dolores |e verfasserin |4 aut | |
| 700 | 1 | |a Gurguí, Mercé |e verfasserin |4 aut | |
| 700 | 1 | |a Fariñas-Alvarez, María Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Mateu, Lourdes |e verfasserin |4 aut | |
| 700 | 1 | |a García Vázquez, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Gálvez-Acebal, Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Carratalà, Jordi |e verfasserin |4 aut | |
| 700 | 0 | |a Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES) Cohort Investigators and the Barcelona Endocarditis Study Team (BEST) |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández Sánchez, Fernando |e investigator |4 oth | |
| 700 | 1 | |a Noureddine, Mariam |e investigator |4 oth | |
| 700 | 1 | |a Rosas, Gabriel |e investigator |4 oth | |
| 700 | 1 | |a de la Torre Lima, Javier |e investigator |4 oth | |
| 700 | 1 | |a Bereciartua, Elena |e investigator |4 oth | |
| 700 | 1 | |a Blanco, Roberto |e investigator |4 oth | |
| 700 | 1 | |a Victoria Boado, María |e investigator |4 oth | |
| 700 | 1 | |a Campaña Lázaro, Marta |e investigator |4 oth | |
| 700 | 1 | |a Crespo, Alejandro |e investigator |4 oth | |
| 700 | 1 | |a Guio Carrión, Laura |e investigator |4 oth | |
| 700 | 1 | |a Del Álamo Martínez de Lagos, Mikel |e investigator |4 oth | |
| 700 | 1 | |a Euba Ugarte, Gorane |e investigator |4 oth | |
| 700 | 1 | |a Goikoetxea, Josune |e investigator |4 oth | |
| 700 | 1 | |a Ibarrola Hierro, Marta |e investigator |4 oth | |
| 700 | 1 | |a Ramón Iruretagoyena, José |e investigator |4 oth | |
| 700 | 1 | |a Irurzun Zuazabal, Josu |e investigator |4 oth | |
| 700 | 1 | |a López-Soria, Leire |e investigator |4 oth | |
| 700 | 1 | |a Montejo, Miguel |e investigator |4 oth | |
| 700 | 1 | |a Nieto, Javier |e investigator |4 oth | |
| 700 | 1 | |a Rodrigo, David |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez, Regino |e investigator |4 oth | |
| 700 | 1 | |a Vitoria, Yolanda |e investigator |4 oth | |
| 700 | 1 | |a Voces, Roberto |e investigator |4 oth | |
| 700 | 1 | |a García López, Mª Victoria |e investigator |4 oth | |
| 700 | 1 | |a Ivanova Georgieva, Radka |e investigator |4 oth | |
| 700 | 1 | |a Ojeda, Guillermo |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez Bailón, Isabel |e investigator |4 oth | |
| 700 | 1 | |a Ruiz Morales, Josefa |e investigator |4 oth | |
| 700 | 1 | |a Azkune Galparsoro, Harkaitz |e investigator |4 oth | |
| 700 | 1 | |a Berritu Boronat, Elisa |e investigator |4 oth | |
| 700 | 1 | |a Bustinduy Odriozola, Mª Jesús |e investigator |4 oth | |
| 700 | 1 | |a Del Bosque Martín, Cristina |e investigator |4 oth | |
| 700 | 1 | |a Echeverría, Tomás |e investigator |4 oth | |
| 700 | 1 | |a Eizaguirre Yarza, Alberto |e investigator |4 oth | |
| 700 | 1 | |a Fuentes, Ana |e investigator |4 oth | |
| 700 | 1 | |a Ángel Goenaga, Miguel |e investigator |4 oth | |
| 700 | 1 | |a Del Río, Muskilda Goyeneche |e investigator |4 oth | |
| 700 | 1 | |a Granda Bauza, Ángela |e investigator |4 oth | |
| 700 | 1 | |a Antonio Iribarren, José |e investigator |4 oth | |
| 700 | 1 | |a Kortajarena Urkola, Xabier |e investigator |4 oth | |
| 700 | 1 | |a Ignacio Pérez-Moreiras López, José |e investigator |4 oth | |
| 700 | 1 | |a Rengel Jiménez, Ainhoa |e investigator |4 oth | |
| 700 | 1 | |a Reviejo, Karlos |e investigator |4 oth | |
| 700 | 1 | |a Sáez Berbejillo, Alberto |e investigator |4 oth | |
| 700 | 1 | |a Sánchez Haza, Elou |e investigator |4 oth | |
| 700 | 1 | |a Sebastián Alda, Rosa |e investigator |4 oth | |
| 700 | 1 | |a Solla Ruiz, Itziar |e investigator |4 oth | |
| 700 | 1 | |a Unamuno Ugartemendia, Irati |e investigator |4 oth | |
| 700 | 1 | |a Vicente Anza, Diego |e investigator |4 oth | |
| 700 | 1 | |a Villanueva Benito, Iñaki |e investigator |4 oth | |
| 700 | 1 | |a Zabalo Arrieta, Mar |e investigator |4 oth | |
| 700 | 1 | |a Carrasco, Rafael |e investigator |4 oth | |
| 700 | 1 | |a Climent, Vicente |e investigator |4 oth | |
| 700 | 1 | |a Llamas, Patricio |e investigator |4 oth | |
| 700 | 1 | |a Merino, Esperanza |e investigator |4 oth | |
| 700 | 1 | |a Plazas, Joaquín |e investigator |4 oth | |
| 700 | 1 | |a Reus, Sergio |e investigator |4 oth | |
| 700 | 1 | |a Álvarez, Nemesio |e investigator |4 oth | |
| 700 | 1 | |a Bravo-Ferrer, José María |e investigator |4 oth | |
| 700 | 1 | |a Castelo, Laura |e investigator |4 oth | |
| 700 | 1 | |a Cuenca, José |e investigator |4 oth | |
| 700 | 1 | |a Llinares, Pedro |e investigator |4 oth | |
| 700 | 1 | |a Miguez Rey, Enrique |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez Mayo, María |e investigator |4 oth | |
| 700 | 1 | |a Sánchez, Efrén |e investigator |4 oth | |
| 700 | 1 | |a Sousa Regueiro, Dolores |e investigator |4 oth | |
| 700 | 1 | |a Javier Martínez, Francisco |e investigator |4 oth | |
| 700 | 1 | |a Del Mar Alonso, Mª |e investigator |4 oth | |
| 700 | 1 | |a Castro, Beatriz |e investigator |4 oth | |
| 700 | 1 | |a Delgado Melian, Teresa |e investigator |4 oth | |
| 700 | 1 | |a Fernández Sarabia, Javier |e investigator |4 oth | |
| 700 | 1 | |a García Rosado, Dácil |e investigator |4 oth | |
| 700 | 1 | |a González González, Julia |e investigator |4 oth | |
| 700 | 1 | |a Lacalzada, Juan |e investigator |4 oth | |
| 700 | 1 | |a de la Peña, Lissete Lorenzo |e investigator |4 oth | |
| 700 | 1 | |a Pérez Ramírez, Alina |e investigator |4 oth | |
| 700 | 1 | |a Prada Arrondo, Pablo |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez Moreno, Fermín |e investigator |4 oth | |
| 700 | 1 | |a Plata Ciezar, Antonio |e investigator |4 oth | |
| 700 | 1 | |a Reguera Iglesias, José Mª |e investigator |4 oth | |
| 700 | 1 | |a Asensi Álvarez, Víctor |e investigator |4 oth | |
| 700 | 1 | |a Costas, Carlos |e investigator |4 oth | |
| 700 | 1 | |a de la Hera, Jesús |e investigator |4 oth | |
| 700 | 1 | |a Fernández Suárez, Jonnathan |e investigator |4 oth | |
| 700 | 1 | |a Iglesias Fraile, Lisardo |e investigator |4 oth | |
| 700 | 1 | |a León Arguero, Víctor |e investigator |4 oth | |
| 700 | 1 | |a López Menéndez, José |e investigator |4 oth | |
| 700 | 1 | |a Mencia Bajo, Pilar |e investigator |4 oth | |
| 700 | 1 | |a Morales, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Moreno Torrico, Alfonso |e investigator |4 oth | |
| 700 | 1 | |a Palomo, Carmen |e investigator |4 oth | |
| 700 | 1 | |a Paya Martínez, Begoña |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez Esteban, Ángeles |e investigator |4 oth | |
| 700 | 1 | |a Rodríguez García, Raquel |e investigator |4 oth | |
| 700 | 1 | |a Telenti Asensio, Mauricio |e investigator |4 oth | |
| 700 | 1 | |a Almela, Manuel |e investigator |4 oth | |
| 700 | 1 | |a Ambrosioni, Juan |e investigator |4 oth | |
| 700 | 1 | |a Azqueta, Manuel |e investigator |4 oth | |
| 700 | 1 | |a Brunet, Mercè |e investigator |4 oth | |
| 700 | 1 | |a Bodro, Marta |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Open forum infectious diseases |d 2014 |g 8(2021), 6 vom: 18. Juni, Seite ofab163 |w (DE-627)NLM243576811 |x 2328-8957 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2021 |g number:6 |g day:18 |g month:06 |g pages:ofab163 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ofid/ofab163 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2021 |e 6 |b 18 |c 06 |h ofab163 | ||